Low-Added Sugar Dietary Intervention Study for Adults with Cystic Fibrosis
Introduction
Adults with cystic fibrosis (CF) are at a higher risk of developing CF-related diabetes (CFRD), which can lead to serious health issues. One contributing factor may be their high intake of added sugars, which are sugars not naturally found in foods. This study aims to explore how reducing added sugar can help improve health outcomes for these individuals.
Study Overview
This ongoing study will involve about 60 adults with stable CF. The main goals are:
- Aim 1: Improve insulin sensitivity and beta-cell function.
- Aim 2: Reduce visceral fat and other harmful fat deposits.
- Aim 3: Enhance overall health by improving blood redox status.
Participants will follow either a low-added sugar diet (less than 5% of calories from added sugars) or a high-added sugar diet (at least 13% of calories from added sugars) for 8 weeks. All meals will be provided, and participants will be monitored regularly to ensure compliance and track health changes.
Ethics and Reporting
This study is funded by the National Institutes of Health (NIH) and has received ethical approval. Findings will be shared with the scientific community through reports and publications.
Trial Registration
The study is registered at ClinicalTrials.gov (NCT05766774).
Practical Solutions and Value
Clinical trials are essential for developing effective treatments. Our AI-driven platform, DocSym, helps clinicians by providing easy access to clinical protocols and research. This streamlining of operations is crucial in today’s healthcare environment, allowing for better patient management and improved outcomes.
Learn more about enhancing your clinic’s workflow and patient care at aidevmd.com.
